Diego Arango Del Corro
Degree: PhD
darango(ELIMINAR)@irblleida.cat
ResearcherID: http://www.researcherid.com/rid/M-5667-2016
Groups
Publications
-
Mariadason JM; Augenlicht LH; Arango D
Microarray analysis in the clinical management of cancer.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17 377-387. .
-
Augenlicht LH; Mariadason JM; Wilson A; Arango D; Yang W; Heerdt BG; Velcich A
Short chain fatty acids and colon cancer.
Journal Of Nutrition 132 -. .
-
Wilson AJ; Velcich A; Arango D; Kurland AR; Shenoy SM; Pezo RC; Levsky JM; Singer RH; Augenlicht LH
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention.
CANCER RESEARCH 62 6006-6010. .
-
Mariadason JM; Arango D; Corner GA; Arañes MJ; Hotchkiss KA; Yang W; Augenlicht LH
A gene expression profile that defines colon cell maturation in vitro.
CANCER RESEARCH 62 4791-4804. .
-
Arango D; Ettarh RR; Holden G; Moriarty M; Brennan PC
BB-10010, an analog of macrophage inflammatory protein-1alpha, protects murine small intestine against radiation.
DIGESTIVE DISEASES AND SCIENCES 46 2608-2614. .
-
Augenlicht LH; Wadler S; Arango D
Clinical response to fluorouracil and p53.
NEW ENGLAND JOURNAL OF MEDICINE 345 1065-1066. .
-
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
CANCER RESEARCH 61 4910-4915. .
-
Stanton MT; Ettarh R; Arango D; Tonra M; Brennan PC
Diagnostic ultrasound induces change within numbers of cryptal mitotic and apoptotic cells in small intestine.
LIFE SCIENCES 68 1471-1475. .
-
Arango D; Ettarh RR; Brennan PC
Dose-effect relationship of BB-10010/MIP-1 alpha on proliferation in murine small intestinal epithelium: single and double administration protocols.
DIGESTIVE DISEASES AND SCIENCES 45 2306-2312. .
-
Arango D; Ettarh RR; Brennan PC
BB-10010, an analogue of macrophage inflammatory protein-1 alpha, reduces proliferation in murine small-intestinal crypts.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 34 68-72. .
Projects
- Contratos predoctorales de formación en investigación en salud (PFIS)
- Nueva aproximación terapéutica para el cáncer colorectal.
- EPH Receptor Signaling in Endometrial Cancer
- Antioxidant treatment as a novel therapeutic option for microvillus inclusion disease. ARMED
- Programa d'Impuls al Talent i l'Ocupabilitat (2021-2024)
- Nueva estrategia terapéutica para ael cáncer gástrico basada en la modulación de la señalización de RHOA
- Desarrollo de nanosistemas de marcaje de CXCR4 mediante radiosondas para la imagen molecular de células tumorales y del microambiente tumoral
- Identificación de nuevos biomarcadores de respuesta a los compuestos regorafenib y TAS-102 en pacientes con cáncer colorrectal.
- Targeting tumor microevironment by a translational multivalent nanomedicine: towards an effective anticancer combination immunotherapy